GIFOF
Grifols SA$7.29 +0.00 (+0.00%)
Oct 27 4:00 PM ET · prev $7.29
1 year
−17.3%
from $8.81 · Oct 28
30 days
+3.0%
from $7.08
52-week range
$7.08–8.85
−18% from high · low Sep 25
Avg volume 20D
110
Oct 21 spike 2.2K
Short interest
126.7K
−13.1%
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- E May 4 Trial readout: T-90d Trial Readout: Alpha-1 MP (Phase 3)
- X Sep 30 Short interest jumps 52.3% to 145.8K
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest −13.1% to 126.7K shares.
- TrendDOWNTREND
10% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 3, 2026 Clinical trial readout
T-90d Trial Readout: Alpha-1 MP (Phase 3)
Trial: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 3, 2026
Trial readout
T-90d Trial Readout: Alpha-1 MP (Phase 3)
Trial: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1…
May 2, 2026
Trial readout
T-90d Trial Readout: Alpha-1 MP (Phase 3)
Trial: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1…
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | — | — | — | $2.2B |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026126,749
shares short
-13.1%
vs prior settlement